A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell MalignanciesElizabeth Budde,Ajay K Gopal,Won Seog Kim,Ian W. Flinn,Chan Yoon Y. Cheah,Loretta Nastoupil,Matthew J. Matasar,Catherine S. Diefenbach,Gareth P Gregory,Ibrahim Qazi,Ching-Fai Pang,Maya Leabman,Genevive Hernandez,Iris Sison,Bruce A. Keyt,Daniel Chen,Philippe ArmandBlood（2021）引用 11|浏览4暂无评分摘要Introduction:更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
